Literature DB >> 22208717

Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps.

P Schaepelynck1, P Darmon, L Molines, M F Jannot-Lamotte, C Treglia, D Raccah.   

Abstract

This review discusses the most recent developments in insulin pump technology. The benefits of the insulin pump to patients with type 1 diabetes are recognized both for its metabolic effectiveness and its positive effects on quality of life. The current pumps are reliable, small and light, and are becoming more and more sophisticated. Nevertheless, there remain practical and psychological constraints for the patient. However, recent patch-pump advances should simplify the technical aspects of pump treatment and enhance patient comfort. Another advance combines the insulin pump with a glucose sensor. Such a combination is logical for optimizing pump use and, to that end, developing an automated or 'closed-loop'system that permits the delivery of subcutaneous insulin adjusted according to measured levels of subcutaneous glucose. Finally, implanted insulin pumps have proven their worth not only because of their simple use, but also for their contribution in the artificial pancreas project. Indeed, the prompt response with intraperitoneal administration of insulin makes it of interest for use in a closed-loop system.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22208717     DOI: 10.1016/S1262-3636(11)70972-7

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  12 in total

1.  Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering.

Authors:  Daniel F Berenson; Allison R Weiss; Zhu-Li Wan; Michael A Weiss
Journal:  Ann N Y Acad Sci       Date:  2012-03-13       Impact factor: 5.691

2.  Patch pump versus conventional pump: postprandial glycemic excursions and the influence of wear time.

Authors:  Yoeri M Luijf; Sabine Arnolds; Angelo Avogaro; Carsten Benesch; Daniela Bruttomesso; Anne Farret; Lutz Heinemann; Jerome Place; Eric Renard; Rachele Scotton; J Hans DeVries
Journal:  Diabetes Technol Ther       Date:  2013-05-07       Impact factor: 6.118

3.  Continuous subcutaneous insulin infusion-an opportunity for better care but not a "magic pill".

Authors:  Avivit Cahn; Eytan Roitman; Genya Aharon-Hananel; Itamar Raz
Journal:  Endocrine       Date:  2016-12-30       Impact factor: 3.633

4.  Patch Pumps: Are They All the Same?

Authors:  Lutz Heinemann; Delia Waldenmaier; Bernd Kulzer; Ralph Ziegler; Barry Ginsberg; Guido Freckmann
Journal:  J Diabetes Sci Technol       Date:  2018-08-22

5.  High Frequency of Dermatological Complications in Children and Adolescents with Type 1 Diabetes: A Web-Based Survey.

Authors:  Fortunato Lombardo; Stefano Passanisi; Davide Tinti; Maria Francesca Messina; Giuseppina Salzano; Ivana Rabbone
Journal:  J Diabetes Sci Technol       Date:  2020-08-06

Review 6.  Design of non-standard insulin analogs for the treatment of diabetes mellitus.

Authors:  V Pandyarajan; M A Weiss
Journal:  Curr Diab Rep       Date:  2012-12       Impact factor: 4.810

Review 7.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Authors:  Samir Mitragotri; Paul A Burke; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-08-08       Impact factor: 84.694

8.  Challenges and Recent Progress in the Development of a Closed-loop Artificial Pancreas.

Authors:  B Wayne Bequette
Journal:  Annu Rev Control       Date:  2012-12       Impact factor: 6.091

Review 9.  Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches.

Authors:  Murugan Prasathkumar; Robert Becky; Salim Anisha; Chenthamara Dhrisya; Subramaniam Sadhasivam
Journal:  Biotechnol Lett       Date:  2022-02-04       Impact factor: 2.461

10.  Phenolic Preservative Removal from Commercial Insulin Formulations Reduces Tissue Inflammation while Maintaining Euglycemia.

Authors:  Adam Mulka; Brianne E Lewis; Li Mao; Roshanak Sharafieh; Shereen Kesserwan; Rong Wu; Donald L Kreutzer; Ulrike Klueh
Journal:  ACS Pharmacol Transl Sci       Date:  2021-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.